This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Information about Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Most recent studies have shown that Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma shares some biological mechanisms with b-cell-lymphomas, cell-transformation-neoplastic, chronic-lymphocytic-leukemia, diffuse-large-b-cell-lymphoma, hodgkin-disease, leukemia, lymphoid-leukemia, lymphoma, lymphoma-follicular, lymphoma-non-hodgkin, lymphoproliferative-disorders, malignant-lymphoma-lymphocytic-intermediate-differentiation-diffuse, malignant-neoplasms, malignant-paraganglionic-neoplasm, marginal-zone-b-cell-lymphoma, mucosa-associated-lymphoid-tissue-lymphoma, neoplasms, richters-syndrome, small-lymphocytic-lymphoma, t-cell-lymphoma.
Among the many pathways, these few ones have gauged particular interests from scientists studying Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma, and have been seen in publications frequently: Aging, Antigenic Variation, Cell Activation, Cell Adhesion, Cell Cycle, Cell Differentiation, Cell Proliferation, Chemotaxis, Histone Acetylation, Immune Response, Interphase, Mismatch Repair, Mitochondrial Depolarization, Pathogenesis, Plasma Cell Differentiation, Protein Phosphorylation, Reverse Transcription, T Cell Activation, Transdifferentiation
Quite a number of genes have been found to play important roles in Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma, such as BCL2, CCND1, CD19, CD38, CD5, CLEC4D, CTLA4, FCER2, FH, FUT4, HLA-DQA1, KRT20, MME, MS4A1, NOD2, PTPRC, SLC35B2, TP53, ZAP70. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.